title: Potential interaction between sevelamer and fat-soluble vitamins: a hypothesis.
authors.forename: Paweena
authors.initials: P
authors.lastname: Susantitaphong
authors.forename: Bertrand L
authors.initials: BL
authors.lastname: Jaber
mesh_terms: D000085:Acetates / Q000627:therapeutic use*; D017610:Calcium Compounds / Q000627:therapeutic use; D019587:Dietary Supplements; D004730:Endothelium, Vascular / Q000503:physiopathology*; D005260:Female; D000089703:Fibroblast Growth Factor-23; D005346:Fibroblast Growth Factors / Q000097:blood*; D005542:Forearm / Q000098:blood supply*; D006801:Humans; D007674:Kidney Diseases / Q000188:drug therapy* / Q000628:therapy*; D008297:Male; D011073:Polyamines / Q000627:therapeutic use*; D012039:Regional Blood Flow / Q000502:physiology*; D006435:Renal Dialysis; D000069603:Sevelamer; D024482:Vitamin K 2 / Q000008:administration & dosage* / Q000627:therapeutic use*; D014813:Vitamin K Deficiency / Q000188:drug therapy*
chemical_list: D000085:Acetates; D017610:Calcium Compounds; D011073:Polyamines; D024482:Vitamin K 2; D005346:Fibroblast Growth Factors; D000089703:Fibroblast Growth Factor-23; D000069603:Sevelamer; C120662:calcium acetate